Supplementary Figure 4. BRAF inhibitor reduces Phospho-ERK in BRAFV600E mutant PMPPDO and PDXO models in a dose dependent manner.
No takes yet. Share an insight, caveat, or question.
Martínez‐Quintanilla et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: